BioSpace News Archive

Wilmington, Delaware, United States: Currently, BCG vaccine is the only available vaccine for tuberculosis.

Pain is invariably around whenever a body is suffering from diseases, which can be of multiple types including fibromyalgia, stomach ulcer, osteoarthritis, chronic arthritis, diabetic neuropathy, and cancer.

Sanofi and GSK announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta vaccine candidate.

Versantis announced data showing both single and repeated intraperitoneal administrations of VS-01 reduced the concentration of several metabolites in the blood associated with infection-related acute-on-chronic liver failure and multiple organ failure related to ACLF.

Burning Rock Biotech Limited announced the resignation of Mr. Jing Rong as a director from the Board, and the appointment of Dr. Licen Lisa Xu as an independent director to the Board.

Össur has pledged to donate prosthetic products and clinical expertise to Ukrainian people in need and has been awarded a €200,000 Euro grant from the Icelandic Ministry for Foreign Affairs’ Sustainable Development Goals (SDG) Partnership Fund to facilitate the accompanying clinical education.

Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that it has fully commenced operations at its new manufacturing Center of Excellence in Clinton, PA.

Green3Bio, a subsidiary of Greenfire Bio, announced a publication in the Journal of Clinical Investigation1 led by researchers at The University of Texas MD Anderson Cancer Center demonstrating that SIK2 inhibitors, including GRN-300 sensitized ovarian and triple-negative breast cancer cells and xenografts to PARP inhibitors.

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the adjuvant treatment of adults and adolescents aged 12 years and older with stage IIB or IIC melanoma and who have undergone complete resection.

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its fourth quarter fiscal 2022 key financial results and provided an update on recent business developments and key upcoming milestones.